A Behavioral Intervention To Improve Hypertension Control In Veterans
NCT ID: NCT00286754
Last Updated: 2015-06-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
533 participants
INTERVENTIONAL
2006-07-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Lower Veterans BP: Patient/Physician Intervention
NCT00105716
Improving Practice Patterns for the Treatment of Hypertension
NCT00265044
Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes
NCT00439816
Working With Veterans Organizations to Improve Blood Pressure
NCT00571038
Self-management of Blood Pressure Medication for Hypertensive Veterans
NCT03224624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Veterans with uncontrolled hypertension (n=533) will be randomized equally to 3 groups: 1) The SMI will use the Transtheoretical model (TTM) as the unifying framework. Veterans will receive TTM stage-matched counseling for exercise, diet, and medications via monthly counseling sessions. A social worker (SW) will assess each participant's behavior and deliver the appropriate tailored SMI based on their stage of change, decisional balance, self-efficacy and the skills model questions. 2) The HEI group receives monthly telephone calls by a SW during which they will receive education about hypertension management. 3) The UC group participates in all the in-person visits but does not receive monthly calls.
There will be an initial 6-month active intervention phase followed by a 6 month monitoring phase to assess sustainability. All participants will visit the VAMC's at baseline and at 3, 6, and 12 months. Outcomes of interest include BP; adherence (to diet, exercise and medications); quality of life; satisfaction; acceptability; cost and cost-effectiveness. Patients will be blinded to which of the intervention arms (SMI or HEI) they are in, SW's will be blinded to patient's BP and staff measuring outcomes will be blinded to study assignment. The study will be analyzed using longitudinal data analysis methods using an intention to treat strategy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stage-matched intervention (SMI)
Stage-matched intervention (SMI)
SMI
Stage-matched intervention
HEI
Health Education Intervention
UC
Usual Care
Health Education Intervention (HEI)
Health Education Intervention (HEI)
SMI
Stage-matched intervention
HEI
Health Education Intervention
UC
Usual Care
Usual Care (UC)
Usual Care (UC)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMI
Stage-matched intervention
HEI
Health Education Intervention
UC
Usual Care
SMI
Stage-matched intervention
HEI
Health Education Intervention
UC
Usual Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults (= 21 years) with hypertension, on antihypertensive medication for = 1 year, and who have current uncontrolled BP will be enrolled.
Patients with CVD:
* chronic stable angina
* unstable angina
* uncomplicated myocardial infarction
* coronary artery bypass surgery
* percutaneous coronary angioplasty
* atherectomy or stent placement
* chronic stable angina pectoris
* stable Class I or Class II congestive heart failure
* stroke
* peripheral vascular disease
will be entered into the study if the CVD event or diagnosis occurred = 6 months ago.
Exclusion Criteria
* terminal illnesses such as terminal cancer
* CVD \< 6 months ago
* Class III or IV CHF
* severe psychiatric illness such as psychosis
* manic depression
* alcohol abuse (\> 21 drinks/week)
* serious chronic conditions like AIDS
* tuberculosis
* lupus
* and end-stage renal failure
will be excluded.
* Other exclusions include inability to understand English
* Lack of a landline telephone
* Unable to follow the study protocol
* Recent major surgery (\< 3 months)
* Patients who are temporarily in the area and plan to move in \< 1 year or will not be available for follow-up
* Those unable to provide informed consent.
* All patients excluded and reason for exclusion will be recorded.
* Prior to recruitment, each patient will be informed about the study and informed consent obtained.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sundar Natarajan, MD MSc
Role: PRINCIPAL_INVESTIGATOR
VA New York Harbor Health Care System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA New York Harbor Health Care System
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ulmer M, Robinaugh D, Friedberg JP, Lipsitz SR, Natarajan S. Usefulness of a run-in period to reduce drop-outs in a randomized controlled trial of a behavioral intervention. Contemp Clin Trials. 2008 Sep;29(5):705-10. doi: 10.1016/j.cct.2008.04.005. Epub 2008 May 6.
Friedberg JP, Lipsitz SR, Natarajan S. Challenges and recommendations for blinding in behavioral interventions illustrated using a case study of a behavioral intervention to lower blood pressure. Patient Educ Couns. 2010 Jan;78(1):5-11. doi: 10.1016/j.pec.2009.04.009. Epub 2009 Jun 13.
Friedberg JP, Rodriguez MA, Watsula ME, Lin I, Wylie-Rosett J, Allegrante JP, Lipsitz SR, Natarajan S. Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial. Hypertension. 2015 Feb;65(2):440-6. doi: 10.1161/HYPERTENSIONAHA.114.03483. Epub 2014 Nov 17.
Rodriguez MA, Wang B, Hyoung S, Friedberg J, Wylie-Rosett J, Fang Y, Allegrante JP, Lipsitz SR, Natarajan S. Sustained Benefit of Alternate Behavioral Interventions to Improve Hypertension Control: A Randomized Clinical Trial. Hypertension. 2021 Jun;77(6):1867-1876. doi: 10.1161/HYPERTENSIONAHA.120.15192. Epub 2021 May 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIR 04-170
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.